[HTML][HTML] Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy

Q Liu, C Jin, Y Wang, X Fang, X Zhang, Z Chen… - NPG Asia …, 2014 - nature.com
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

[HTML][HTML] Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy

Q Liu, C Jin, Y Wang, X Fang, X Zhang, Z Chen… - NPG Asia …, 2014 - ncbi.nlm.nih.gov
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy.

Q Liu, C Jin, Y Wang, X Fang, X Zhang, Z Chen… - NPG Asia …, 2014 - europepmc.org
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

[PDF][PDF] Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy

Q Liu, C Jin, Y Wang, X Fang, X Zhang, Z Chen, W Tan - 2014 - cyberleninka.org
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy

Q Liu, C Jin, Y Wang, X Fang, X Zhang… - NPG Asia …, 2014 - pubmed.ncbi.nlm.nih.gov
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy.

Q Liu, C Jin, Y Wang, X Fang, X Zhang, Z Chen… - NPG Asia …, 2014 - europepmc.org
Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …